Pancreatic Cancer Research

ResearcherOslo University HospitalNo recent work listed

Svein Dueland

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6125-6689; OpenAlex author ID A5056318188. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 5

  1. Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data from a population-based, prospective coho… Co-author DOI 10.1093/bjsopen/zrad137↗
  2. Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer. Co-author DOI 10.1007/s11523-016-0469-y↗
  3. Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) - study protocol for a natio… Last author DOI 10.1186/s12893-017-0291-1↗
  4. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first … Co-author DOI 10.3109/0284186x.2015.1068445↗
  5. hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes. First author DOI 10.1007/s00262-011-0991-9↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Knut Jørgen Labori · 3 shared papers, 2016–2023 · strength 0.30
  2. Caroline Sophie Verbeke · 2 shared papers, 2017–2023 · strength 0.24
  3. Lars Aabakken · 1 shared paper, 2023 · strength 0.18
  4. Dyre Berg Kleive · 1 shared paper, 2023 · strength 0.18
  5. Ingvild Farnes · 1 shared paper, 2023 · strength 0.18
  6. Pål‐Dag Line · 1 shared paper, 2023 · strength 0.18
  7. Dag Hoem · 1 shared paper, 2017 · strength 0.07
  8. Kristoffer Lassen · 1 shared paper, 2017 · strength 0.07
  9. Rune Smaaland · 1 shared paper, 2017 · strength 0.07
  10. Matthew H. G. Katz · 1 shared paper, 2016 · strength 0.05
  11. Bjørn Atle Bjørnbeth · 1 shared paper, 2016 · strength 0.05
  12. Bjørn Edwin · 1 shared paper, 2016 · strength 0.05
  13. Elin Hegland Kure · 1 shared paper, 2016 · strength 0.05
  14. Ivar P. Gladhaug · 1 shared paper, 2016 · strength 0.05
  15. Trond A Buanes · 1 shared paper, 2016 · strength 0.05
  16. Michael Haas · 1 shared paper, 2017 · strength 0.05
  17. Uwe M. Martens · 1 shared paper, 2017 · strength 0.05
  18. Jean‐Luc Van Laethem · 1 shared paper, 2017 · strength 0.05
  19. Paul J. Ross · 1 shared paper, 2017 · strength 0.05
  20. Bohuslav Melichar · 1 shared paper, 2017 · strength 0.05
  21. Marc Peeters · 1 shared paper, 2017 · strength 0.05
  22. Barrett H. Childs · 1 shared paper, 2017 · strength 0.05
  23. Patrick Michl · 1 shared paper, 2017 · strength 0.05
  24. Hanno B. Riess · 1 shared paper, 2017 · strength 0.05
  25. Alberto Zaniboni · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.